Macrophage Pharma
Mark Krul is the current director at Macrophage Pharma. Prior to this, they were with Cristal Therapeutics, ISA Pharmaceuticals B.V., Aglaia Oncology Fund II, and Macrophage Pharma Ltd. Mark has also worked as a research manager at the European Cancer Center. Mark has over 25 years of experience in the pharmaceutical industry, with a focus on oncology drug development.
Mark Krul attended the Katholiek Gelders Lyceum, Arnhem for high school and then went on to Utrecht University where they obtained their Ph.D. in medical biology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Macrophage Pharma
Macrophage Pharma is an immuno-oncology company focused on the discovery and development of novel therapies designed to enhance anti-tumour immune responses.